Antipyretic agents for preventing recurrences of febrile seizures: Randomized controlled trial

Archives of Pediatrics and Adolescent Medicine

Volumn 163, Issue 9, 2009, Pages 799-804

  Strengell, Teemu ^a   Uhari, Matti ^a   Tarkka, Rita ^a,b   Uusimaa, Johanna ^a   Alen, Reija ^c   Lautala, Pentti ^d,e   Rantala, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^e SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; IBUPROFEN; PARACETAMOL; PLACEBO;

ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEBRILE CONVULSION; FEMALE; FEVER; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT DURATION; TREATMENT RESPONSE;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IBUPROFEN; INFANT; MALE; PLACEBOS; RECURRENCE; SEIZURES, FEBRILE; SUPPOSITORIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349097713     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2009.137     Document Type: Article

References (21)

1. Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics. 1978;61(5):720-727.
2. Berg AT, Shinnar S, Hauser WA, Leventhal JM. Predictors of recurrent febrile seizures: a meta-analytic review. J Pediatr. 1990;116(3):329-337. (Pubitemid 20109781)
3. Offringa M, Hazebroek-Kampschreur AA, Derksen-Lubsen G. Prevalence of febrile seizures in Dutch schoolchildren. Paediatr Perinat Epidemiol. 1991;5(2):181-188.
4. Rantala H, Uhari M, Hietala J. Factors triggering the first febrile seizure. Acta Paediatr. 1995;84(4):407-410.
5. Shinnar S, Berg AT, Moshe SL, et al. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics. 1990;85(6):1076-1085. (Pubitemid 20184732)
6. Tarkka R, Rantala H, Uhari M, Pokka T. Risk of recurrence and outcome after the first febrile seizure. Pediatr Neurol. 1998;18(3):218-220. (Pubitemid 28169338)
7. Verity CM, Butler NR, Golding J. Febrile convulsions in a national cohort followed up from birth, II: medical history and intellectual ability at 5 years of age. Br Med J (Clin Res Ed). 1985;290(6478):1311-1315. (Pubitemid 15082106)
8. Verity CM, Ross EM, Golding J. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. BMJ. 1993;307(6898):225-228. (Pubitemid 23207898)
9. Uhari M, Rantala H, Vainionpää L, Kurttila R. Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatr. 1995;126(6):991-995.
10. van Stuijvenberg M, Derksen-Lubsen G, Steyerberg EW, Habbema JD, Moll HA. Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile seizure recurrences. Pediatrics. 1998;102(5):E51.
11. Rantala H, Tarkka R, Uhari M. Systematic review of the role of prostaglandins and their synthetase inhibitors with respect to febrile seizures. Epilepsy Res. 2001;46(3):251-257. (Pubitemid 32772814)
12. 2α concentrations in the cerebrospinal fluid of children with febrile convulsions, epilepsy and meningitis. Brain Dev. 1983;5(4):357-362.
13. Löscher W, Siemes H. Increased concentration of prostaglandin E-2 in cerebrospinal fluid of children with febrile convulsions. Epilepsia. 1988;29(3):307-310. (Pubitemid 18135937)
14. Aronoff DM, Neilson EG. Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med. 2001;111(4):304-315. (Pubitemid 32885627)
15. Armitage P, Berry G, Matthews JNS. Analysing means and proportions. In: Statistical Methods in Medical Research. 4th ed. Oxford, England: Blackwell Science; 2002:124-125.
16. Camfield PR, Camfield CS, Shapiro SH, Cummings C. The first febrile seizure: antipyretic instruction plus either phenobarbital or placebo to prevent recurrence. J Pediatr. 1980;97(1):16-21. (Pubitemid 10033756)
17. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993;90(24):11693-11697. (Pubitemid 24008705)
18. Berg AT. Are febrile seizures provoked by a rapid rise in temperature? Am J Dis Child. 1993;147(10):1101-1103.
19. Keinänen-Kiukaanniemi S, Similä S, Käpylä H. Antipyretic therapy: evaluation of diclofenac sodium as an antipyretic agent. Clin Ther. 1980;2:421-426. (Pubitemid 10070988)
20. Polman HA, Huijbers WA, Augusteijn R. The use of diclofenac sodium (Voltaren®) suppositories as an antipyretic in children with fever due to acute infections: a double-blind, between-patient, placebo-controlled study. J Int Med Res. 1981;9(5):343-348. (Pubitemid 11005112)
21. Van Esch A, Van Steensel-Moll HA, Steyerberg EW, Offringa M, Habbema JDF, Derksen-Lubsen G. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 1995;149(6):632-637.